Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2010
12/30/2010US20100333238 Method For Inducing Resistance To Fungal Infection In Transgenic Plants Using Plant Defense Peptides
12/30/2010US20100333235 Plant Centromere Compositions
12/30/2010US20100333231 Maize Promoter P95 and Methods of Use
12/30/2010US20100333230 Closterovirus vectors and methods
12/30/2010US20100333227 Pepper hybrid bs02838720
12/30/2010US20100333226 Pepper hybrid bs02827989
12/30/2010US20100333225 Pepper hybrid bs02827975
12/30/2010US20100333224 Pepper hybrid bs02828008
12/30/2010US20100333223 Carbohydrate binding plant hydrolases which alter plant cell walls
12/30/2010US20100333222 Knockout mice for a p450 gene cluster
12/30/2010US20100333218 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto
12/30/2010US20100333216 Non-human gene-disrupted animal with disrupted Adam11 gene
12/30/2010US20100331980 Aligned scaffolding system for skeletal muscle regeneration
12/30/2010US20100331964 Ex Vivo Remodeling of Excised Blood Vessels for Vascular Grafts
12/30/2010US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions
12/30/2010US20100331534 nucleic acid purification method
12/30/2010US20100331418 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal
12/30/2010US20100331392 Antidotes to antisense compounds
12/30/2010US20100331391 Zap-70 as predictor and modulator of effector function of t cells
12/30/2010US20100331390 Effects of apolipoprotein b inhibition on gene expression profiles in animals
12/30/2010US20100331389 Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides
12/30/2010US20100331344 Modulators of ATP-Binding Cassette Transporters
12/30/2010US20100331335 Inhibitors of Jun N-Terminal Kinase
12/30/2010US20100331328 Bicyclylaryl-aryl-amine compounds and their use
12/30/2010US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides
12/30/2010US20100331297 Modulation of protein trafficking
12/30/2010US20100331280 Modulation of the Phospholipase A2 Pathway as a Therapeutic
12/30/2010US20100331268 Nitrated Lipids and Methods of Making and Using Thereof
12/30/2010US20100331255 Compositions and Methods for Increasing Production of Recombinant Gamma-Carboxylated Proteins
12/30/2010US20100331253 Method for cell adhesion and wound healing
12/30/2010US20100331251 Polypeptides homologous to vegf and bmp1
12/30/2010US20100331250 Anti-angiogenesis fusion proteins
12/30/2010US20100331239 Cd14 and peptides thereof for protection of cells against cell death
12/30/2010US20100331237 Gag binding proteins
12/30/2010US20100331216 Cell culture method
12/30/2010US20100331206 Compositions and methods for early pregnancy diagnosis
12/30/2010US20100331197 System and method for the clonal culture of epithelial cells and applications thereof
12/30/2010US20100330677 Improved Reprogramming of Mammalian Cells, and Cells Obtained
12/30/2010US20100330676 Expression of surrogate light chains
12/30/2010US20100330675 Insulating polynucleotides derived from element d4z4 and their uses in transgenesis
12/30/2010US20100330674 Cell culture support and associated method for cell growth and release
12/30/2010US20100330673 Methods of making enhanced, autologous fat grafts
12/30/2010US20100330672 Human stem cells originating from human amniotic mesenchymal cell layer
12/30/2010US20100330671 Molecular transporters based on sugar and its analogues and processes for the preparation thereof
12/30/2010US20100330670 Differentiated Pluripotent Stem Cell Progeny Depleted of Extraneous Phenotypes
12/30/2010US20100330669 Fvii or fviia variants
12/30/2010US20100330668 Interaction Between the VHL Tumour Suppressor and Hypoxia Inducible Factor, and Assay Methods Relating Thereto
12/30/2010US20100330665 Method for producing a cell culture substrate
12/30/2010US20100330644 Boundary conditions for the arrangement of cells and tissues
12/30/2010US20100330617 Methods of Producing a Secreted Protein
12/30/2010US20100330613 Methods for determining efficacy of chemotherapeutic agents
12/30/2010US20100330608 Molecular transporters based on sugar and its analogues and processes for the preparation thereof
12/30/2010US20100330602 Use of Soluble Galectin-3 (Gal-3) for Cancer Treatment
12/30/2010US20100330591 GPCR Expressing Cell Lines and Antibodies
12/30/2010US20100330590 Assays using chimeric t1r3 taste receptor polypeptides
12/30/2010US20100330584 Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
12/30/2010US20100330572 Organic compounds
12/30/2010US20100330560 Immunogenic polypeptide isolated from mycobacterium avium subspecies paratuberculosis and uses thereof
12/30/2010US20100330213 Estrogenic Extracts of Morus Alba and Uses Thereof
12/30/2010US20100330182 Tendon Stem Cells
12/30/2010US20100330159 System for transporting active substances in a biological system
12/30/2010US20100330155 METHODS AND COMPOSITIONS FOR IMPROVED THERAPEUTIC EFFECTS WITH siRNA
12/30/2010US20100330154 amphoteric liposomes comprising neutral lipids
12/30/2010US20100330143 Modified macromolecules and methods of making and using thereof
12/30/2010US20100330121 Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330114 Use of SIRT1 Activators or Inhibitors to Modulate an Immune Response
12/30/2010US20100330104 Methods of using btl-ii proteins
12/30/2010US20100330101 BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
12/30/2010US20100330100 Pseudomonas aeruginosa-outer membrane protein pa4710
12/30/2010US20100330098 Methods to regulate glucose metabolism
12/30/2010US20100330095 Axl antibodies
12/30/2010US20100330092 Monoclonal antibody having neutralizing activity against mmp13
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330088 Strategies to prevent and/or treat immunie responses to soluble allofactors
12/30/2010US20100330087 Methods for treating cancer using combination therapy
12/30/2010US20100330086 Cationic steroid antimicrobial compositions and methods of use
12/30/2010US20100330082 Nlrr-1 antagonists and uses thereof
12/30/2010US20100330080 Antigen binding polypeptides
12/30/2010US20100330076 Immunoglobulin fc polypeptides
12/30/2010US20100330075 Monoclonal human tumor-specific antibody
12/30/2010US20100330073 Methods of treatment using antibodies to neutrokine-alpha
12/30/2010US20100330072 Myostatin binding agents
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330068 Monomeric vhh domain derived from anti-vp6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections
12/30/2010US20100330063 Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
12/30/2010US20100330059 Chimeric factor vii molecules
12/30/2010US20100330057 Method of evaluating human dentritic cells and human cell immunotherapeutic agent
12/30/2010US20100330056 Enhanced generation of cytotoxic t-lymphocytes by il-21 mediated foxp3 suppression
12/30/2010US20100330053 Mixed-cell gene therapy
12/30/2010US20100330052 Use of Mesenchymal Stem Cells for Treating Genetic Diseases and Disorders
12/30/2010US20100330051 Polypeptide having an improved cytosine deaminase activity
12/30/2010US20100330050 Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division
12/30/2010US20100330049 Method for generating islet beta cells from dedifferentiated exocrine pancreatic cells
12/30/2010US20100330048 Mesenchymal stem cells and uses therefor
12/30/2010US20100330047 Mesenchymal Stem Cells Grown Under Hypoxic Conditions: Compositions, Methods and Uses Therefor
12/30/2010US20100330046 Human skin substitutes expressing il-12
12/30/2010US20100330045 Mesenchymal precursor cell
12/30/2010US20100330044 Mesp1 as a master regulator of multipotent cardiovascular progenitor specification and uses thereof
12/30/2010US20100330043 Gpr125 as a marker for stem and progenitor cells and methods use thereof
1 ... 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 ... 1827